Oral ketamine vs placebo in patients with cancer-related neuropathic pain: a randomized clinical trial

Fallon, M. T., Wilcock, A., Kelly, C. A., Paul, J. , Lewsley, L.-A., Norrie, J. and Laird, B. J.A. (2018) Oral ketamine vs placebo in patients with cancer-related neuropathic pain: a randomized clinical trial. JAMA Oncology, 4(6), pp. 870-872. (doi:10.1001/jamaoncol.2018.0131) (PMID:29621378) (PMCID:PMC6145686)

[img]
Preview
Text
160562.pdf - Published Version
Available under License Creative Commons Attribution.

210kB

Abstract

No abstract available.

Item Type:Articles (Letter)
Keywords:General medicine.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Paul, Mr James and Lewsley, Ms Liz-Anne and Kelly, Mrs Caroline
Authors: Fallon, M. T., Wilcock, A., Kelly, C. A., Paul, J., Lewsley, L.-A., Norrie, J., and Laird, B. J.A.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
Journal Name:JAMA Oncology
Publisher:American Medical Association
ISSN:2374-2437
ISSN (Online):2374-2445
Published Online:05 April 2018
Copyright Holders:Copyright © 2018 Fallon MT et al.
First Published:First published in JAMA Oncology 4(6): 870-872
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
469284KPS (Ketamine Pain Study): A randomised double-blind controlled trial of S-Ketamine versus placebo in conjunction with best pain management in neuropathic pain in cancer patientsJames PaulCancer Research UK (CRUK)C17958/A14197RI CANCER SCIENCES